07 Mar 2018
United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United...
21 Feb 2018
United Therapeutics Corporation Reports 2017 Fourth Quarter And Annual Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Actavis Laboratories...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2017 financial results...
SOUTH SAN FRANCISCO, Calif. and SILVER SPRING, Md., Jan. 3, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR), a leading biotechnology company focused on development of therapies for the treatment of...
28 Dec 2017
United Therapeutics Corporation To Present At 36th Annual J.P. Morgan Healthcare Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of...
20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca®
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2017."Our...
23 Oct 2017
United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation System
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a new...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2017 financial results before the...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2017 /PRNewswire/ -- Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is featured in Forbes...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the independent data monitoring committee (DMC) for the FREEDOM-EV...